Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review

BACKGROUND: Measuring cumulative clinical treatment benefit over time captures speed and magnitude of effects. Assessing the cost of biologics relative to their cumulative clinical benefits versus a single time point represents an alternative to evaluate the value of a given biologic used to treat p...

Descripción completa

Detalles Bibliográficos
Autores principales: Blauvelt, Andrew, Burge, Russel, Malatestinic, William, Brnabic, Alan, Guo, Jiaying, Janardhanan, Manju, Zhu, Baojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391184/
https://www.ncbi.nlm.nih.gov/pubmed/33377444
http://dx.doi.org/10.18553/jmcp.2021.27.1.084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391184/
https://www.ncbi.nlm.nih.gov/pubmed/33377444
http://dx.doi.org/10.18553/jmcp.2021.27.1.084

Ejemplares similares